These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9580775)

  • 1. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor.
    Schmitt B; Steinmann B; Gitzelmann R; Thun-Hohenstein L; Mascher H; Dumermuth G
    Neurology; 1993 Feb; 43(2):421-4. PubMed ID: 8437713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R; Gammeltoft K; Matteson K
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M; Kitajima H; Tokoro T; Kubo M; Maekawa K
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
    Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
    J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
    J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan in infantile nonketotic hyperglycinemia.
    Schmitt B; Steinmann B
    J Pediatr; 1993 Feb; 122(2):324-5. PubMed ID: 8429455
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia.
    Boneh A; Degani Y; Harari M
    Pediatr Neurol; 1996 Sep; 15(2):137-41. PubMed ID: 8888048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan in nonketotic hyperglycinemia.
    Allen RJ
    Neurology; 1993 Nov; 43(11):2422-3. PubMed ID: 8110239
    [No Abstract]   [Full Text] [Related]  

  • 14. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
    Van Hove JL; Vande Kerckhove K; Hennermann JB; Mahieu V; Declercq P; Mertens S; De Becker M; Kishnani PS; Jaeken J
    J Inherit Metab Dis; 2005; 28(5):651-63. PubMed ID: 16151895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan in a child with nonketotic hyperglycinaemia--a 6-year follow up.
    Schmitt B; Steinmann B
    Eur J Pediatr; 1998 Apr; 157(4):349-50. PubMed ID: 9578977
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal nonketotic hyperglycinemia.
    Bhamkar RP; Colaco P
    Indian J Pediatr; 2007 Dec; 74(12):1124-6. PubMed ID: 18174652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventeen-year long-term survival of a case of neonatal nonketotic hyperglycinemia.
    Ichikawa K; Inami Y; Kaneko K
    Pediatr Int; 2020 Sep; 62(9):1111-1113. PubMed ID: 32754929
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).
    Magwebu ZE; Mazinu M; Abdul-Rasool S; Chauke CG
    Metab Brain Dis; 2019 Oct; 34(5):1467-1472. PubMed ID: 31230217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.